1398 – Implantation of a permanent leadless and batteryless haemodynamic sensor and associated remote analysis of pulmonary artery pressure for patients with moderate chronic heart failure (New York Heart Association class III).

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Deferred

Application details

Reason for application

New MBS item.

Service or technology in this application

Implantation of a permanent wireless haemodynamic sensor and associated remote analysis of pulmonary artery pressure for patients with moderate chronic heart failure (New York Heart Association class III).

Type: Investigative

Medical condition this application addresses

Heart failure is a complex clinical syndrome that is characterised by an underlying structural abnormality or cardiac dysfunction that impairs the ability of the heart ventricle to fill and / or eject blood. Heart failure usually manifests among patients as dyspnoea, with subsequent symptoms including fluid overload and confusion. Patients with heart failure often have limited exercise capacity, high mortality rates, and impaired quality of life. Acute decompensated heart failure, during which patients suffer a sudden worsening or deterioration of signs and symptoms, frequently leads to hospitalisation.

Meetings to consider this application

  • PASC meeting: 
    • 16 April 2014
    • 11-12 December 2014
  • ESC meeting: 8 October 2015
  • MSAC meeting: 26 November 2015